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Microbial studiesAbstract An extensive characterization study on the novel series of synthesized sydnone, chalcone
and pyrimidine is reported in this paper. A series of 3-(4-chlorophenyl)-4-{[4-(3-substitutedphenylac-
ryloyl)phenyl]sulfamoyl}-sydnone and 3-(4-chlorophenyl)-4-[4-(4-aminophenyl)-6-substitutedphe-
nylpyrimidin-2-aminesulfonyl]-sydnone are synthesized. The structures of the synthesized compounds
were characterized by elemental analysis, IR, 1H NMR, 13C NMR and mass spectroscopy. An exclu-
sive study on microbial activity using various microbial strains was also undertaken to support and
conﬁrm our experimental ﬁndings.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Sydnones are most important member of the mesoionic cate-
gory of compounds. Sydnone derivatives have been viewed
as exotic structures within the heterocyclic community. With
few exceptions, sydnones are stable compounds that exhibit
signiﬁcant polarity. A hydrogen atom at the fourth position
of the sydnone ring allows substitution with a wide variety
of electrophiles, with retention of the ring, typical of aromatic
substrates (Asundaria and Patel, 2010). A large number of syd-
none derivatives have been synthesized (Ollis and Ramsden,1976; Kier and Roche, 1967) as they serve to be vital biological
agents viz, antitumor (Bos and Leischhacker, 1984) antiviral
(Dunkley and Thoman, 2003), analgesic, anti-inﬂammatory,
anthelmintic (Mukesh and Tandon, 2006), antimicrobial
(Kalluraya et al., 2002), free radical scavenging (Kavali and
Badami, 2000) and nitric oxide donor (Mallur et al., 2007),
activities. Present study seeks to synthesized series of novel
chalcone (Al-Jaber et al., 2012), and Pyrimidine (Patel and
Mehta, 2010; Hussein, 2010), derivatives that contain such
important sydnonyl moiety, with the aim of obtaining new bio-
logically active compounds. As a part of this work we have
used sydnone based a-b-unsaturated ketone derivatives (chal-
cone) as useful precursors in the synthesis of the corresponding
pyrimidine derivatives. Sydnones exhibit biological activities
(Reddy and Sarma Rama, 1993; Prasad et al., 2008; Lim
et al., 2007; Mishra et al., 2008; Rani et al., 2004), similar to
pyrimidine which is the basic nucleus in DNA and RNA.
Studies have claimed the use of pyrimidine derivatives efﬁcient
curing drug for thyroid and leukemia (Supaluk et al., 2009). In
view of the continued interest in developing the simpler and
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heterocyclic systems were investigated (Jin et al., 2007; Cheng
et al., 2008).2. Results and discussion
2.1. Chemistry
The synthesis of sydnone, chalcone and pyrimidine deriva-
tives examined are shown in the Scheme 1. Initial step in-
volves the dehydration of N-alkyl or aryl N-nitroso-a-
amino acid which is the only general route to sydnones.
For the formation of sydnones by ring closure of N-substi-
tuted N-nitrosoglycines, it is evident that at least one hydro-
gen atom is required on the a-carbon atom and that the
amino nitrogen atom should have a substituent other than
hydrogen. However, when an N-alkyl-N-nitroso-a-amino
dicarboxylic acid is treated with acetic anhydride, sydnone
ring competes with the cyclic acid anhydride formation by
dehydration between the two carboxyl groups and the result
is rather complicated. In the case of nitrosoiminodiacetic
acid, 3-carboxy methyl sydnone is obtained instead of the
corresponding cyclic anhydride (Stewart, 1963). Synthesis of
3-(4-chlorophenyl)-4-[4(acetylphenyl)sulfamoyl]-sydnone as
described in the scheme. Chalcones (8a–j) were carried out
by condensing 3-(4-chlorophenyl)-4-[4(acetylphenyl) sulfa-
moyl]-sydnone with different substituted aldehyde in dilute
ethanolic sodium hydroxide solution at room temperature.
The compounds (9a–j) were synthesized by the reaction of
the chalcones (8a–j) with guanidine nitrate using sodium
ethoxide in ethanol. Yield of the novel compounds were
found between 62% and 89% depending upon reactivity of
the substituted aldehyde.
All the compounds gave satisfactory elemental analysis. IR
and NMR spectral measurements conﬁrmed the correct ap-
proach of synthesis. The expected spectral features of synthe-
sized compounds have been assigned.
Compounds belonging to 8a–j series showed typical sharp
absorptions at tmax 1773 cm
1 which is characteristic –C‚Oband
of the sydnone, a sharp band of styryl –C‚O at 1662 cm1,
–CH‚CH– of chalcone at 1599 cm1 and the asymmetric and
symmetric band of –SO2 at 1353 cm
1 and 1173 cm1, respec-
tively, were observed. The 1H NMR spectra exhibited doublet
at d 6.65–6.67 ppm which attributed the ‚CH–CO– protons
and second doublet at d 7.38–7.41 ppm conﬁrmed the presence
of ‚CH2-Ar group. In
13C NMR of the chalcone, the
–CH‚CH– carbon signals appeared at the d 146.47 and
123.48 ppm, respectively. The high-ﬁeld resonance at d
190.76 ppm was attributed to the carbonyl group present in
chalcone. The structures of compounds 9a–j were also con-
ﬁrmed using IR and NMR spectroscopy. The IR spectra of
the pyrimidine showed no styryl –C‚O band at 1662 cm1
but there were new asymmetric and symmetric broad bands
at 3355 and 3220 cm1, respectively, for –NH2. Signals at d
5.15 ppm and d 7.85 ppm for the –NH2 and –CH of the pyrim-
idine ring were observed in 1H NMR spectrum and the pyrim-
idine –CH carbon resonance appeared at d 102.38 ppm in the
13C NMR spectra. On the basis of the above spectral data the
structures of the compounds 8a–j and 9a–j compounds were
conﬁrmed.2.2. Experimental
2.2.1. General
All the melting points reported are uncorrected and were re-
corded using an Electro Thermal Melting Point apparatus.
Elemental analyses (C, H and N) were performed at G.N.F.C.
(Gujarat Narmda Valley Fertilizer Company Ltd., Bharuch).
Fourier transform infrared spectra were recorded with a Ther-
mo Scientiﬁc Nicolet ISO-10 spectrophotometer in the fre-
quency range 4000–400 cm1 with samples embedded in KBr
discs. Proton nuclear magnetic resonance (1H NMR) spectra
of the compound were recorded with a Bruker Avance II 400
NMR using DMSO-d6 as a solvent and tetramethylsilane as
an internal reference. Carbon (13C) NMR spectra of the com-
pounds were recorded with a Bruker Avance II 400 NMR
spectrometer at SAIF (Sophisticated Analytical Instrument
Facilities), Chandigarh. Thin-layer chromatography analyses
were performed by using aluminium-backed silica-gel plates
(Merck 60 F524) and examined under short-wave ultraviolet
(UV) light.2.2.2. Synthesis of ethyl N-(4-chlorophenyl)glycinate (2)
p-Chloroaniline (1.40 g, 1.0 mmol), chloroethyl acetate (1.06 mL,
0.01 mol) in ethanol (10 mL) and anhydrous sodium acetate
(1.64 g, 2.0 mmol) were reﬂuxed for 5 h. The mixture was di-
luted with 10 mL of water and kept in refrigerator overnight.
Recrystallization in ethanol gave 81% yield of pure glycinate.
M.p. 116 C. IR (KBr): 3328 cm1(N–H Str.), 2951, 2887 cm1,
(C–H Str. aliphatic), 1757 (C–O Str. of ester), 1604, 1511 cm1
(C‚C Str. of aromatic), 1072, 750 cm1 (C–Cl), 1H NMR
(DMSO-d6): d 1.21 (t, 3H, COOCH2CH3), 3.76 (s, 1H, NH),
4.29 (s, 2H, CH2), 4.54 (q, 2H, COOCH2CH3), 6.83–7.21 (m,
4H, Ar- H); 13C NMR (400 MHz, DMSO-d6): d 14.67 ppm
(CH3), 115.12–146.26 ppm (Ar-C), 172.11 ppm (C–O).2.2.3. Synthesis of N-(4-chlorophenyl)glycine (3)
Compound 2 (2.13 g, 1.0 mmol) and sodium hydroxide (0.6 g,
1.5 mmol) in solution of distilled water and ethanol (18:4 mL)
was heated at 80–85 C for 0.5 h. Allowed to cool and acidiﬁed
with hydrochloric acid. Crystalline white product was ob-
tained. Yield 78%. M.p. 146 C. IR (KBr): 3323 cm1(N–H
Str.), 3278 cm1 (O–H Str. of acid), 1705 cm1 (C–O Str. of
acid), 1604, 1511 cm1 (C‚C Str. of aromatic), 1067, 750 cm1
(C–Cl); 1H NMR (400MHz, DMSO-d6): d 4.33 (s, 2H, CH2),
6.44 (s, 1H, COOH), 6.52 (s, 1H, NH), 6.88–7.23 (m, 4H,
Ar-H); 13C NMR (400MHz, DMSO-d6): d 114.32–146.07 ppm
(Ar-C), 172.18 ppm (C–O).2.2.4. Synthesis of [(4-chlorophenyl)(nitroso)amino]acetic
acid (4)
To an ice cooled solution of the 3 (1.86 g, 1.0 mmol) in water
(40 mL), a solution of sodium nitrite (0.69 g, 1.0 mmol) in
water (5 mL) was added drop wise with stirring. The reaction
mixture was ﬁltered and precipitated by adding concentrated
hydrochloric acid to the ﬁltrate. Yellowish needles were ob-
tained as product. Yield 84%. M.p. 105 C. IR (KBr):
3257 cm1 (O–H Str. of acid), 1712 cm1 (C–O Str. of acid),
1604, 1511 cm1 (C‚C Str. of aromatic), 1571, 1328 cm1
(N‚O), 1065, 750 cm1 (C–Cl); 1H NMR(400 MHz,
DMSO-d6): d 5.02 (s, 2H, CH2), 6.93–7.48 (m, 4H, Ar-H),
Scheme 1 3-(4-Chlorophenyl)-4-{[4-(3-substitutedphenyl acryloyl) phenyl] sulfamoyl}-sydnone (8a–j) and 3-(4-chlorophenyl)-4-(N-(4-
(2-amino-4-(substitutedphenyl) pyrimidin-5-yl) phenyl) sulfamoyl)-sydnone (9a–j).
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120.78–138.89 ppm (Ar-C), 168.24 ppm (C–O).
2.2.5. Synthesis of 3-(4-chlorophenyl)sydnone (5)
The mixture of 4 (2.70 g, 1.26 mmol) and acetic anhydride
(15 mL) was stirred at room temperature for 12 h in dark.The solution was poured slowly into cold water which was very
well stirred. The pH of the content was adjusted to 7.0 with
10% sodium bicarbonate solution. The crude sydnone ob-
tained was washed well with water and dried. Recrystallization
from 95% ethanol afforded yield 98% of light yellow needles,
m.p. 140–145 C. IR (KBr): 3078 cm1 (C–H of aromatic),
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NMR (400 MHz, DMSO-d6): d 7.21 (s, 1H, sydnone), 7.52–
8.16 (m, 4H, Ar-H); 13C NMR (40 MHz, DMSO-d6): d
74.28 ppm (C‚O of sydnone), 98.86 ppm (CH of sydnone),
124.12–149.19 ppm (Ar-C).
2.2.6. Synthesis of 3-(4-chlorophenyl)-4-
[chlorosulfonyl]sydnone (6)
Add 5 (1.96 g, 1.0 mmol) in small portion to the mixture of
chlororsulphonic acid (0.70 mL, 0.01 mol) and catalytic
amount of phosphorous pentoxide. Shake well to ensure thor-
ough mixing. When the addition has been made, heat the reac-
tion mixture at 60–65 C for about 1 h in order to complete the
reaction. Allow to cool and pour the mixture over ice. Stir well.
Brown solid product was obtained. Filter off the product and
wash with cold water. Yield 89%. M.p. 196 C. IR (KBr):
1777 cm-1(C‚O of sydnone), 1345, 1178 cm1(S‚O), 1056,
822 cm1 (C–Cl); 1H NMR (400 MHz, DMSO-d6): d 7.13–
7.95 (m, 4H, Ar-H); 13C NMR (400 MHz, DMSO-d6): d
74.28 ppm (C‚O of sydnone), 115.86 ppm (CH of sydnone),
117.89–149.54 ppm (Ar-C).
2.2.7. Synthesis of 3-(4-chlorophenyl)-4-
[4(acetylphenyl)sulfamoyl]-sydnone (7)
4-Amino acetophenone (1.35 g, 1.0 mmol) in acetone (10 mL)
was added to 6 (2.56 g, 1.0 mmol) with stirring for 4 h. Add
pyridine (2.0 mL) in portion within this period. Pour the solu-
tion to the ice cold water. Light yellow solid product was ob-
tained. Yield 89%. M.p. 168 C. IR (KBr): 1777 cm1 (C‚O
of sydnone), 1689 cm1 (C‚O of acetophenon) 1347,
1174 cm1(S‚O), 1056, 823 cm1 (C–Cl); 1H NMR
(400 MHz, DMSO-d6): d 2.56 (s, 3H,CH3), 7.13–7.95 (m, 8H,
Ar-H); 13C NMR (400 MHz, DMSO-d6): d 75.16 ppm (C‚O
of sydnone), 115.70 ppm (CH of sydnone), 119.26–
143.63 ppm (Ar-C), 197.20 ppm (C‚O of acetophenon).
2.2.8. General synthesis of the compounds 8a–j
To a well stirred solution of 7 (1.0 mmol) and substituted benz-
aldehyde (1.0 mmol) in ethanol (98 mL) and 20% NaOH solu-
tion (10 mL) was added. The reaction mixture was stirred for
thirty minutes at room temperature and left over night. After
the completion of reaction, it was poured into ice water, prod-
ucts recrystallized in alcohol. Similarly other derivatives were
prepared.
2.2.8.1. 3-(4-Chlorophenyl)-4-(N-(4-(3-(4-methoxyphenyl)
acryloyl)phenyl)sulfamoyl)-sydnone (8a). Yield 89%. M.p.
171 C. IR (KBr): 2917, 2840 cm1 (–OCH3), 1773 cm1
(C‚O, sydnone), 1663 cm1 (C‚O, styryl ketone), 1599 cm1
(CH‚CH), 1351, 1156 cm1 (–SO2), 822 (C–Cl);
1H NMR
(DMSO-d6): d 3.84 ppm (s, 2H, OCH3), 6.67 ppm (d, 1H,
CH–CO), 7.38 ppm (d, 1H, CH), 7.59–8.05 ppm (m, 12H,
Ar-H), 9.67 ppm (s, 1H, SO2NH);
13C NMR (400 MHz,
DMSO-d6): d 53.82 ppm (OCH3), 107.26 ppm (CHof sydnone),
113.78–158.92 ppm (Ar-C), 123.77, 143.50 ppm (CH‚CH),
169.10 ppm (C‚O of sydnone), 190.76 ppm (C‚O of
chalcone); MS: m/z (rel. int.%) 511 (M)+. Anal. (%) for
C24H18N3O6SCl, Calcd: C, 56.31; H, 3.54; N, 8.21; Found: C,
56.38; H, 3.49; N, 8.23.
2.2.8.2. 3-(4-Chlorophenyl)-4-(N-(4-(3-p-tolylacryloyl) phenyl)
sulfamoyl)-sydnone (8b). Yield 72%. M.p. 132 C. IR (KBr):2924, 2824 cm1 (–CH3), 1766 cm
1 (–C‚O, sydnone),
1662 cm1 (–C‚O, styryl ketone), 1599 cm1 (–CH‚CH),
1351, 1116 cm1 (–SO2), 2926, 2834 cm
1 (–CH3), 826 cm
1
(–C–Cl); 1H NMR (DMSO-d6): d 1.17 ppm (t, 3H, CH3),
6.66 ppm (d, 1H,‚CH–CO), 7.39 ppm (d, 1H, –CH), 7.58–
8.08 ppm (m, 12H, Ar-H), 9.69 ppm (s, 1H, –SO2NH);
13C
NMR (400 MHz, DMSO-d6): d 21.32 ppm (CH3),
107.82 ppm (CH of sydnone), 113.78–156.23 ppm (Ar-C),
124.38, 143.90 ppm (CH‚CH), 170.32 ppm (C‚O of syd-
none), 191.47 ppm (C‚O of chalcone); MS: m/z (rel. int.%)
495 (M)+. Anal. (%) for C24H18N3O5SCl, Calcd: C, 58.12;
H, 3.66; N, 8.47; Found: C, 58.11; H, 3.69; N, 8.46.
2.2.8.3. 3-(4-Chlorophenyl)-4-(N-(4-(3-(2-chlorophenyl)acry-
loyl)phenyl)sulfamoyl)-sydnone (8c). Yield 78%. M.p. 190 C.
IR (KBr): 1743 cm1 (–C‚O, sydnone), 1660 cm1 (–C‚O,
styryl ketone), 1592 cm1 (–CH‚CH), 1349, 1166 cm1
(–SO2), 814 cm
1 (–C–Cl); 1H NMR (DMSO-d6): d 6.65 ppm
(d, 1H, ‚CH–CO), 7.37 ppm (d, 1H, –CH), 7.59–8.06 ppm
(m, 12H, Ar-H), 9.68 ppm (s, 1H, –SO2NH);
13C NMR
(DMSO-d6): d 109.32 ppm (CH of sydnone), 115.13–160.17 ppm
(Ar-C), 123.21, 143.67 ppm (CH‚CH), 171.56 ppm (C‚Oof
sydnone), 192.16 ppm (C‚O of chalcone); MS: m/z (rel.
int.%) 515 (M-1)+. Anal. (%) for C23H15N3O5SCl2, Calcd:
C, 53.50; H, 2.93; N, 8.14; Found: C, 53.54; H, 2.97; N, 8.10.
2.2.8.4. 3-(4-Chlorophenyl)-4-(N-(4-(3-(2-nitrophenyl)acryloyl)
phenyl)sulfamoyl)-sydnone (8d). Yield 70%. M.p. 137 C. IR
(KBr): 1751 cm1 (–C‚O, sydnone), 1660 cm1 (–C‚O, sty-
ryl ketone), 1595 cm1 (–CH‚CH), 1350, 1143 cm1 (–SO2),
827 cm1 (–C–Cl); 1H NMR (DMSO-d6): d 6.67 ppm (d, 1H,
‚CH–CO), 7.37 ppm (d, 1H, –CH), 7.60–8.07 ppm (m, 12H,
Ar-H), 9.69 ppm (s, 1H, –SO2NH);
13C NMR (DMSO-d6): d
108.92 ppm (CH of sydnone), 117.13–160.12 ppm (Ar-C),
124.76, 144.10 ppm (CH‚CH), 170.14 ppm (C‚O of syd-
none), 190.27 ppm (C‚O of chalcone); MS: m/z (rel. int.%)
526 (M)+. Anal. (%) for C23H15N4O7SCl, Calcd: C, 52.43;
H, 2.87; N, 10.63; Found: C, 52.49; H, 2.82; N, 10.67.
2.2.8.5. 3-(4-Chlorophenyl)-4-(N-(4-(3-(4-ﬂuorophenyl)acry-
loyl)phenyl)sulfamoyl)-sydnone (8e). Yield 68%. M.p. 148 C.
IR (KBr): 1765 cm1 (–C‚O, sydnone), 1661 cm1 (–C‚O,
styryl ketone), 1594 cm1 (–CH‚CH), 1355, 1150 cm1
(–SO2), 976 cm
1 (-C-F), 829 cm1 (–C–Cl); 1H NMR
(DMSO-d6): d 6.67 ppm (d, 1H, ‚CH–CO), 7.37 ppm (d,
1H, –CH), 7.59–8.08 ppm (m, 12H, Ar-H), 9.65 ppm (s, 1H,
–SO2NH);
13C NMR (DMSO-d6): d 109.14 ppm (CH of
sydnone), 118.23–160.17 ppm (Ar-C), 123.44, 144.13 ppm
(CH‚CH), 171.52 ppm (C‚Oof sydnone), 192.28 ppm
(C‚O of chalcone); MS: m/z (rel. int.%) 500 (M+1)+. Anal.
(%) for C23H15N3O5SFCl, Calcd: C, 55.26; H, 3.02; N, 8.41;
Found: C, 55.21; H, 3.10; N, 8.43.
2.2.8.6. 3-(4-Chlorophenyl)-4-(N-(4-(3-(4-(dimethylamino)
phenyl)acryloyl)phenyl) sulfamoyl)-sydnone (8f). Yield73%.
M.p. 159 C. IR (KBr): 3375 cm1 (-OH), 1756 cm1
(–C‚O, sydnone), 1664 cm1 (–C‚O, styryl ketone),
1598 cm1 (–CH‚CH), 1347, 1158 cm1 (–SO2), 827 cm
1
(–C–Cl); 1H NMR (DMSO-d6): d 1.67 ppm (t, 3H, CH3),
6.66 ppm (d, 1H, ‚CH–CO), 7.37 ppm (d, 1H, –CH), 7.58–
8.06 ppm (m, 12H, Ar-H), 9.66 ppm (s, 1H, –SO2NH);
13C
NMR (DMSO-d6): d 41.62 ppm (CH3), 108.63 ppm (CH of
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(CH‚CH), 172.12 ppm (C‚O of sydnone), 190.84 ppm
(C‚O of chalcone); MS: m/z (rel. int.%) 523 (M-1)+. Anal.
(%) for C25H21N4O5SCl, Calcd: C, 57.20; H, 4.03; N, 10.67;
Found: C, 57.19; H, 4.03; N, 10.61.
2.2.8.7. 3-(4-Chlorophenyl)-4-(N-(4-(3-(4-chlorophenyl)acry-
loyl)phenyl)sulfamoyl)-sydnone (8g). Yield 66%. M.p. 145 C.
IR (KBr): 1770 cm1 (–C‚O, sydnone), 1657 cm1 (–C‚O,
styryl ketone), 1589 cm1 (–CH‚CH), 1357, 1150 cm1
(–SO2), 819 cm
1 (–C–Cl); 1H NMR (DMSO-d6): 6.67 ppm
(d, 1H, ‚CH–CO), 7.36 ppm (d, 1H, –CH), 7.59–8.07 ppm
(m, 12H, Ar-H), 9.68 ppm (s, 1H, –SO2NH);
13C NMR
(DMSO-d6): d 109.53 ppm (CH of sydnone), 116.67–
168.11 ppm (Ar-C), 124.12, 145.57 ppm (CH‚CH),
170.56 ppm (C‚O of sydnone), 192.43 ppm (C‚O of chal-
cone); MS: m/z (rel. int.%) 515 (M-1)+. Anal. (%) for
C23H15N3O5SCl2, Calcd: C, 53.50; H, 2.93; N, 8.14; Found:
C, 53.43; H, 2.96; N, 8.17.2.2.8.8. 3-(4-Chlorophenyl)-4-(N-(4-(3-(4-hydroxyphenyl)
acryloyl)phenyl)sulfamoyl)-sydnone (8h). Yield 65%. M.p.
152 C. IR (KBr): 3351 cm1 (–OH), 1768 cm1 (–C‚O,
sydnone), 1660 cm1 (–C‚O, styryl ketone), 1595 cm1
(–CH‚CH), 1352, 1152 cm1 (–SO2), 825 cm
1 (–C–Cl); 1H
NMR (DMSO-d6): d 6.66 ppm (d, 1H, ‚CH–CO), 7.37 ppm
(d, 1H, –CH),7.60–8.06 ppm (m, 12H, Ar-H), 9.68 ppm (s,
1H, –SO2NH);
13C NMR (DMSO-d6): d 108.33 ppm (CH of
sydnone), 115.84–159.21 ppm (Ar-C), 124.67, 144.52 ppm
(CH‚CH), 171.74 ppm (C‚O of sydnone), 192.04 ppm
(C‚O of chalcone); MS: m/z (rel. int.%) 498 (M+1)+. Anal.
(%) for C23H16N3O6SCl, Calcd: C, 55.48; H, 3.24; N, 8.44;
Found: C, 55.41; H, 3.20; N, 8.42.2.2.8.9. 3-(4-Chlorophenyl)-4-(N-(4-(3-(4-(diethylamino)-2-
hydroxyphenyl)acryloyl)phenyl)sulfamoyl)-sydnone (8i).
Yield 72%. M.p. 140 C. IR (KBr): 3358 cm1 (-OH), 2914,
2846 cm1 (–CH3), 1773 cm
1 (–C‚O, sydnone), 1658 cm1
(–C‚O, styryl ketone), 1598 cm1 (–CH‚CH), 1346,
1153 cm1 (–SO2), 821 cm
1 (–C–Cl); 1H NMR (DMSO-d6):
d 6.67 ppm (d, 1H, ‚CH–CO), 7.37 ppm (d, 1H, –CH),
7.59–8.05 ppm (m, 12H, Ar-H), 9.66 ppm (s, 1H, –SO2NH);
13C NMR (DMSO-d6): d 13.21 ppm (CH2), 49.33 ppm
(CH3), 108.71 ppm (CH of sydnone), 114.12–168.68 ppm
(Ar-C), 124.47, 146.51 ppm (CH‚CH), 169.68 ppm (C‚O
of sydnone), 192.19 ppm (C‚O of chalcone); MS: m/z (rel.
int.%) 569 (M)+. Anal. (%) for C27H25N4O6SCl, Calcd: C,
56.99; H, 4.43; N, 9.85; Found: C, 56.97; H, 4.46; N, 9.81.2.2.8.10. 3-(4-Chlorophenyl)-4-(N-(4-(3-phenylacryloyl)
phenyl)sulfamoyl)-sydnone (8j). Yield 76%. M.p. 136 C. IR
(KBr): 1757 cm1 (–C‚O, sydnone), 1657 cm1 (–C‚O, sty-
ryl ketone), 1596 cm1 (–CH‚CH), 1350, 1157 cm1 (–SO2),
824 cm1 (–C–Cl); 1H NMR (DMSO-d6): d 6.65 ppm (d, 1H,
‚CH–CO), 7.38 ppm (d, 1H, –CH), 7.60–8.07 ppm (m, 12H,
Ar-H), 9.67 ppm (s, 1H, –SO2NH);
13C NMR (DMSO-d6): d
108.12 ppm (CH of sydnone), 115.47–169.78 ppm (Ar-C),
124.87, 147.92 ppm (CH‚CH), 171.64 ppm (C‚O of syd-
none), 191.53 ppm (C‚O of chalcone); MS: m/z (rel. int.%)
481 (M)+. Anal. (%) for C23H16N3O5SCl, Calcd: C, 57.32;
H, 3.35; N, 8.72; Found: C, 57.26; H, 3.38; N, 8.70.2.2.9. General preparation of the compounds 9a–j
A mixture of freshly prepared solution of sodium ethoxide
(2.0 mmol Na in 50 mL ethanol), 8a–j (1.0 mmol) and guani-
dine nitrate (1.0 mmol) was heated at reﬂux for 8–12 h, reac-
tion progress was monitored by TLC (toluene/ethyl acetate,
7.5:2.5). After completion of the reaction the mixture was con-
centrated under vacuum and remaining material was poured
onto crushed ice. The solid produced was separated and stirred
for 1 h to maintain pH neutral with dilute acetic acid. The
resulting solid was ﬁltered off and washed with cold ethanol,
dried and recrystallized from ethanol.
2.2.9.1. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-(4-methoxy-
phenyl)pyrimidin-5-yl)phenyl) sulfamoyl)-sydnone (9a). Yield
62%. M.p. 195 C. IR (KBr): 3358, 3227 cm1 (–NH2),
2917,2840 cm1 (–OCH3), 1749 cm
1 (–C‚O, sydnone),
1602 cm1 (–C‚N), 1342, 1151 cm1 (–SO2), 828 cm
1 (–C–
Cl); 1H NMR (DMSO-d6): d 3.83 ppm (s, 2H, –OCH3–),
5.12 ppm (s, 2H, –NH2), 7.60–8.07 ppm (m, 12H, Ar-H),
7.86 ppm (s, 1H, pyrimidine-NH), 9.62 ppm (s, 1H, –SO2NH);
13C NMR (DMSO-d6): d 53.82 ppm (OCH3), 108.26 ppm (CH
of sydnone), 113.59–158.92 ppm (Ar-C), 123.48, 143.50 ppm
(CH‚CH), 163.60 ppm (C–NH2 of pyrimidine), 169.60 ppm
(C‚O of sydnone); MS: m/z (rel. int.%) 551 (M+1)+. Anal.
(%) for C25H19N6O5SCl, Calcd: C, 54.50; H, 3.48; N, 15.25;
Found: C, 54.53; H, 3.49; N, 15.22.
2.2.9.2. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-p-tolylpyrimi-
din-5-yl)phenyl)sulfamoyl)-sydnone (9b). Yield 69%. M.p.
221 C. IR (KBr): 3352, 3224 cm1 (–NH2), 2924, 2854 cm1
(–CH3), 1749 cm
1 (–C‚O, sydnone), 1609 cm1 (–C‚N),
1346, 1158 cm1 (–SO2), 827 cm
1 (–C–Cl); 1H NMR
(DMSO-d6): d 1.17 ppm (t, 3H, –CH3), 5.16 ppm (s, 2H, –
NH2), 7.54–8.27 ppm (m, 12H, Ar-H), 7.78 ppm (s, 1H, pyrim-
idine-NH), 9.69 ppm (s, 1H, –SO2NH);
13C NMR (DMSO-d6):
d 21.36 ppm (CH3), 109.21 ppm (CH of sydnone), 112.62–
159.26 ppm (Ar-C), 123.16, 144.76 ppm (CH‚CH), 164.13 ppm
(C–NH2 of pyrimidine), 169.52 ppm (C‚O of sydnone); MS:
m/z (rel. int.%) 533 (M-1)+. Anal. (%) for C25H19N6O4SCl,
Calcd: C, 56.13; H, 3.58; N, 15.71; Found: C, 56.16; H, 3.54;
N, 15.76.
2.2.9.3. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-(2-chlorophenyl)
pyrimidin-5-yl)phenyl) sulfamoyl)-sydnone (9c). Yield 81%.
M.p. 189 C. IR (KBr): 3355, 3224 cm1 (–NH2), 1749 cm1
(–C‚O, sydnone), 1607 cm1 (–C‚N), 1338, 1157 cm1
(–SO2), 823 cm
1 (–C–Cl) cm1; 1H NMR (DMSO-d6): d
5.21 ppm (s, 2H, –NH2), 7.68–8.02 ppm (m, 12H, Ar-H),
7.82 ppm (s, 1H, pyrimidine-NH), 9.61 ppm (s, 1H, –SO2NH);
13C NMR (DMSO-d6): d 108.64 ppm (CH of sydnone),
112.29–159.15 ppm (Ar-C), 123.18, 143.48 ppm (CH‚CH),
163.16 ppm (C–NH2 of pyrimidine), 169.83 ppm (C‚O of
sydnone); MS: m/z (rel. int.%) 554 (M-1)+. Anal. (%) for
C24H16N6O4SCl2, Calcd: C, 51.90; H, 2.90; N, 15.13; Found:
C, 51.86; H, 2.93; N, 15.15.
2.2.9.4. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-(2-nitrophenyl)
pyrimidin-5-yl)phenyl) sulfamoyl)-sydnone (9d). Yield 79%.
M.p. 216 C. IR (KBr): 3348, 3219 cm1 (–NH2), 1751 cm1
(–C‚O, sydnone), 1611 cm1 (–C‚N), 1535,1352 cm1
(-NO2), 1340, 1149 cm
1 (–SO2), 825 cm
1 (–C–Cl); 1H
NMR (DMSO-d6): d 5.18 ppm (s, 2H, –NH2), 7.78–8.21 ppm
198 Y.M. Patel, K.C. Patel(m, 12H, Ar-H), 7.84 ppm (s, 1H, pyrimidine-NH), 9.58 ppm
(s, 1H, –SO2NH);
13C NMR (DMSO-d6): d 107.22 ppm (CH
of sydnone), 114.95–158.94 ppm (Ar-C), 124.16, 143.06 ppm
(CH‚CH), 163.72 ppm (C–NH2 of pyrimidine), 170.24 ppm
(C‚O of sydnone); MS: m/z (rel. int.%) 565 (M)+.Anal.
(%) for C24H16N7O6SCl, Calcd: C, 50.93; H, 2.85; N, 17.32;
Found: C, 50.83; H, 2.87; N, 17.30.
2.2.9.5. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-(4-ﬂuorophenyl)
pyrimidin-5-yl)phenyl)sulfamoyl)-sydnone (9e). Yield74%.
M.p. 258 C. IR (KBr): 3355, 3220 cm1 (–NH2), 1765 cm1
(–C‚O, sydnone), 1606 cm1 (–C‚N), 1343, 1159 cm1
(–SO2), 975 cm
1 (–C–F), 826 cm1 (–C–Cl); 1H NMR
(DMSO-d6): d 5.10 ppm (s, 2H, –NH2), 7.69–8.16 ppm (m,
12H, Ar-H), 7.76 ppm (s, 1H, pyrimidine-NH), 9.66 ppm (s,
1H, –SO2NH);
13C NMR (DMSO-d6): d 107.43 ppm (CH of
sydnone), 113.56–158.82 ppm (Ar-C), 125.48, 144.17 ppm
(CH‚CH), 164.54 ppm (C–NH2 of pyrimidine), 169.47 ppm
(C‚O of sydnone); MS: m/z (rel. int.%) 537 (M-1)+.Anal.
(%) for C24H16N6O4SFCl, Calcd: C, 53.49; H, 2.99; N,
15.59; Found: C, 53.47; H, 2.94; N, 15.50.
2.2.9.6. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-(4-(dimethyl-
amino)phenyl)pyrimidin-5-yl)phenyl)sulfamoyl)-sydnone (9f).
Yield 89%. M.p. 168 C. IR (KBr): 3356, 3225 cm1 (–NH2),
2914, 2846 cm1 (–CH3), 1747 cm
1 (–C‚O, sydnone),
1600 cm1 (–C‚N), 1349, 1091 cm1 (–SO2), 819 cm
1 (–C–
Cl); 1H NMR (DMSO-d6): d 1.29 ppm (t, 6H, –CH3),
5.15 ppm (s, 2H, –NH2), 7.54–7.97 ppm (m, 12H, Ar-H),
7.79 ppm (s, 1H, pyrimidine-NH), 9.68 ppm (s, 1H, –SO2NH);
13C NMR (DMSO-d6): d 41.32 ppm (CH3), 108.56 ppm (CH of
sydnone), 115.14–159.24 ppm (Ar-C), 123.26, 142.52 ppm
(CH‚CH), 164.69 ppm (C–NH2 of pyrimidine), 169.69 ppm
(C‚O of sydnone); MS: m/z (rel. int.%) 563 (M-1)+. Anal.
(%) for C26H22N7O4SCl, Calcd: C, 55.37; H, 3.93; N, 17.38;
Found: C, 55.31; H, 3.93; N, 17.34.
2.2.9.7. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-(4-chlorophenyl)
pyrimidin-5-yl)phenyl) sulfamoyl)-sydnone (9g). Yield 82%.
M.p. 226 C. IR (KBr): 3356, 3222 cm1 (–NH2), 1752 cm1
(–C‚O, sydnone), 1608 cm1 (–C‚N), 1341, 1158 cm1
(–SO2), 826 cm
1 (–C–Cl); 1H NMR (DMSO-d6): d 5.07 ppm
(s, 2H, –NH2), 7.67–8.27 ppm (m, 12H, Ar-H), 7.91 ppm (s,
1H, pyrimidine-NH), 9.67 ppm (s, 1H, –SO2NH);
13C NMR
(DMSO-d6): d 107.14 ppm (CH of sydnone), 115.16–
157.26 ppm (Ar-C), 124.18, 142.56 ppm (CH‚CH),
163.28 ppm (C–NH2 of pyrimidine), 169.12 ppm (C‚O of
sydnone); MS: m/z (rel. int.%) 556 (M+1)+. Anal. (%) for
C24H16N6O4SCl2, Calcd: C, 51.90; H, 2.90; N, 15.13; Found:
C, 50.84; H, 2.83; N, 17.38.
2.2.9.8. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-(4-hydroxy-
phenyl)pyrimidin-5-yl)phenyl) sulfamoyl)-sydnone (9h). Yield
86%. M.p. 249 C. IR (KBr): 3347, 3222 cm1 (–NH2),
3357 cm1 (–OH), 1743 cm1 (–C‚O, sydnone), 1610 cm1
(–C‚N), 1340, 1148 cm1 (–SO2), 821 cm
1 (–C–Cl); 1H
NMR (DMSO-d6): d 5.07 ppm (s, 2H, –NH2), 7.63–8.06 ppm
(m, 12H, Ar-H), 7.90 ppm (s, 1H, pyrimidine-NH), 9.57 ppm
(s, 1H, –SO2NH);
13C NMR (DMSO-d6): d 108.28 ppm (CH
of sydnone), 116.96–161.36 ppm (Ar-C), 123.34, 142.29 ppm
(CH‚CH), 164.39 ppm (C–NH2 of pyrimidine), 169.72 ppm
(C‚O of sydnone); MS: m/z (rel. int.%) 536 (M)+. Anal.(%) for C24H17N6O5SCl, Calcd: C, 53.68; H, 3.19; N, 15.65;
Found: C, 53.61; H, 3.14; N, 15.62.
2.2.9.9. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-(4-(diethyl-
amino)-2-hydroxyphenyl) pyrimidin-5-yl)phenyl)sulfamoyl)-
sydnone (9i). Yield 79%. M.p. 178 C. IR (KBr): 3354,
3225 cm1 (–NH2), 1746 cm
1 (–C‚O, sydnone), 1604 cm1
(–C‚N), 1341, 1151 cm1 (–SO2), 827 cm
1 (–C–Cl); 1H
NMR (DMSO-d6): d 5.13 ppm (s, 2H, –NH2), 7.70–8.23 ppm
(m, 12H, Ar-H), 7.88 ppm (s, 1H, pyrimidine-NH), 9.72 ppm
(s, 1H, –SO2NH);
13C NMR (DMSO-d6): d 13.21 ppm
(CH2), 47.34 ppm (CH3), 107.61 ppm (CH of sydnone),
114.96–159.24 ppm (Ar-C), 123.46, 143.31 ppm (CH‚CH),
164.22 ppm (C–NH2 of pyrimidine), 169.77 ppm (C‚O of
sydnone); MS: m/z (rel. int.%) 607 (M-1)+. Anal. (%) for
C28H26N7O5SCl, Calcd: C, 55.31; H, 4.31; N, 16.12; Found:
C, 55.24; H, 4.36; N, 16.13.
2.2.9.10. 3-(4-Chlorophenyl)-4-(N-(4-(2-amino-4-phenylpyrim-
idin-5-yl)phenyl)sulfamoyl)-sydnone (9j). Yield 72%. M.p.
206 C. IR (KBr): 3356, 3227 cm1 (–NH2), 1747 cm1
(–C‚O, sydnone), 1601 cm1 (–C‚N), 1346, 1151 cm1
(–SO2), 823 cm
1 (–C–Cl); 1H NMR (DMSO-d6): d 5.14 ppm
(s, 2H, –NH2), 7.62–8.10 ppm (m, 12H, Ar-H), 7.82 ppm (s,
1H, pyrimidine-NH), 9.67 ppm (s, 1H,–SO2NH);
13C NMR
(DMSO-d6): d 107.93 ppm (CH of sydnone), 114.46–159.24 ppm
(Ar-C), 124.46, 142.64 ppm (CH‚CH), 163.53 ppm (C–NH2
of pyrimidine), 169.10 ppm (C‚O of sydnone); MS: m/z (rel.
int.%) 520 (M)+. Anal. (%) for C24H17N6O4SCl, Calcd: C,
55.33; H, 3.29; N, 16.13; Found: C, 55.38; H, 3.21; N, 16.16.
2.2.9.11. Biological activity. Antibacterial activity of tested
compoundswere assessed againstmicrococcus viz.Staphylococ-
cus aureus (S. aureus), Bacillus subtilis (B. subtillis), Escherichia
coli (E. coli), and Pseudomonas aeruginosa (P. aeruginosa) by
broth dilution method (Stalons and Thornsberry, 1975). Cipro-
ﬂoxacin and Metronidazole were used as reference drugs. N,N-
dimethylformamide (DMF)was used as solvent for this activity.
The twofold dilution of the compounds were prepared (400,
200, 100, 50, 25) lg/mL in the same solvent forMinimum Inhib-
itory Concentration (MIC). The compounds were screened
under identical conditions at a dose of 200 lg/mL with DMF
as solvent. Antifungal activities against Candida albicans
(C. albicans) organisms were compared with standard drugs
Fluconazole by similar method.
2.2.10. Antibacterial activity
From screening results, substituted chalcones 8 g (4-Cl) possess
very good activity against Gram +ve and Gram ve bacteria
as compared with standard drugs. The remaining chalcones
possesses moderate to poor activity against all four bacterial
species and the corresponding pyrimidine derivatives, 9b
(4-CH3) exhibited very good activity against E. coli, S. aureus,
and P. aeruginosa. The remaining pyrimidines displayed mod-
erate to poor activities against all four bacterial species.
2.2.11. Antifungal activity
Antifungal screening data showed that chalcone 8e (4-F) exhi-
bit high promising activity against C. albicans. Pyrimidine 9f
(4-N(CH3)2) possessed excellent activity against C. albicans.
The remaining compounds of the entire series exhibit moderate
to poor activity.
Synthesis and biological evaluation of new sydnone based derivatives 1993. Conclusions
Our present investigation centers the studies on synthesis, spec-
tral analysis and biological activities of sydnone based chal-
cone and pyrimidine derivatives. The procedure proved to be
more proﬁtable than those previously reported in the litera-
ture. Some compounds were found to be very effective as anti-
bacterial and antifungal agents. The presence of chloro/ﬂuoro
group at the p-position in phenyl ring of chalcone derivatives
appears to be electron acceptor group. While the presence of
methyl group also present at the p-position in phenyl ring of
pyrimidine derivatives have reported to be electron donating
group which in parts them good biological activity as inferred
from structure–activity relationship (SAR) studies.
References
Al-Jaber, N.A., Bougasim, A.S.A., Karah, M.M.S., 2012. J. Saudi
Chem. Soc. 16, 45–53.
Asundaria, S.T., Patel, K.C., 2010. Synth. Commun. 40, 1899–1906.
Bos, M., Leischhacker, W.F., 1984. Pharm. Unserer Zeit 13, 51–56.
Cheng, J.H., Hung, C.F., Yang, S.C., Wang, J.P., Wond, S.J., Lin,
C.N., 2008. Bioorg. Med. Chem. 16, 7270–7276.
Dunkley, C.S., Thoman, C.J., 2003. Bioorg. Med. Chem. Lett. 13,
2899–2901.
Hussein, A.M., 2010. J. Saudi Chem. Soc. 14, 61–68.Jin, F., Jin, X.Y., Jin, Y.L., Sohn, D.W., Kim, S.A., Sohn, D.H., Kim,
Y.C., Kim, H.S., 2007. Arch. Pharm. Res. 30, 1359–1367.
Kalluraya, B., Rahiman, M.A., Banji, D., 2002. Ind. J. Chem. 41B,
1712–1717.
Kavali, J.R., Badami, B.V., 2000. Farmaco 55, 406–409.
Kier, L.B., Roche, E.B., 1967. J. Pharm. Sci. 56, 149–168.
Lim, S.S., Kim, H.S., Lee, D.U., 2007. Bull. Korean Chem. Soc. 28,
2495–2497.
Mallur, S.G., Tiwari, A.K., Chinna Raju, B., Suresh Babu, K., Zehra
Ali, A., Sastry, B.S., Madhusudana Rao, J., 2007. Ind. J. Chem.
46B, 1686–1689.
Mishra, N., Arora, P., Kumar, B., Mishra, L.C., Bhattacharya, A.,
Awasthi, S.K., Bhasin, V.K., 2008. Eur. J. Med. Chem. 43, 1530–1535.
Mukesh, V.K., Tandon, M., 2006. Ind. J. Heterocycl. Chem. 15, 399–
400.
Ollis, W.D., Ramsden, C.A., 1976. Adv. Heterocycl. Chem. 19, 1.
Patel, A.A., Mehta, A.G., 2010. J. Saudi Chem. Soc. 14, 203–208.
Prasad, Y.R., Kumar, P.R.D., Smiles, J., Babu, P.A., 2008. Arkivoc
11, 266–276.
Rani, P., Srivastava, V.K., Kumar, A., 2004. Eur. J. Med. Chem. 39,
449–452.
Reddy, V.M., Sarma Rama, G.V.S., 1993. Ind. J. Heterocycl. Chem. 3,
111–116.
Stalons, D.R., Thornsberry, C., 1975. Antimicrob. Agents Chemother.
7, 15–21.
Stewart, F.H.C., 1963. J. Chem. Soc., 701–706.
Supaluk, P., Nirun, S., Ratchanok, P., Apilak, W., Somsak, R.,
Virapong, P., 2009. Molecules 14, 2768–2779.
